Related Experiment Videos

Purging of peripheral blood progenitor cells

W Brugger¹, S Scheding, W Vogel

¹Department of Haematology, University of Tübingen, Germany.

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|January 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2019

[Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example].

Pneumologie (Stuttgart, Germany)·2018

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC).

Journal of cancer research and clinical oncology·2018

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017

Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).

Annals of oncology : official journal of the European Society for Medical Oncology·2016

See all related articles